Premium
Flutiform, a new steroid/long‐acting beta‐agonist inhaler
Author(s) -
Chaplin Steve,
Thomson Neil
Publication year - 2013
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1043
Subject(s) - formoterol , medicine , inhaler , formoterol fumarate , asthma , beta (programming language) , agonist , b2 receptor , fluticasone , pharmacology , steroid , budesonide , receptor , hormone , computer science , bradykinin , programming language
Abstract Flutiform is a new inhaled steroid/long‐acting beta‐agonist combination containing fluticasone and formoterol. Here, the authors give details of the clinical trial results regarding its efficacy and safety and discuss its place in the treatment of asthma.